A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 114,053 shares of MRK stock, worth $10.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
114,053
Previous 112,056 1.78%
Holding current value
$10.9 Million
Previous $13.9 Million 6.64%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $221,966 - $257,553
1,997 Added 1.78%
114,053 $13 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $1.02 Million - $1.1 Million
8,269 Added 7.97%
112,056 $13.9 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $20,722 - $24,146
-183 Reduced 0.18%
103,787 $13.7 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $374,673 - $407,734
-3,740 Reduced 3.47%
103,970 $11.3 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $368,869 - $409,644
-3,583 Reduced 3.22%
107,710 $11.1 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $325,504 - $354,784
-2,997 Reduced 2.62%
111,293 $12.8 Million
Q1 2023

May 16, 2023

SELL
$102.94 - $114.86 $6.06 Million - $6.77 Million
-58,905 Reduced 34.01%
114,290 $12.2 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $93,385 - $119,733
-1,068 Reduced 0.61%
173,195 $19.2 Million
Q3 2022

Nov 16, 2022

BUY
$84.53 - $94.96 $14.7 Million - $16.5 Million
174,263 New
174,263 $15 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $9.52 Million - $10.7 Million
-112,649 Closed
0 $15 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $1.05 Million - $1.19 Million
-12,585 Reduced 10.05%
112,649 $10.3 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $65,423 - $73,336
890 Added 0.72%
125,234 $10.3 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $3.07 Million - $3.85 Million
-42,522 Reduced 25.48%
124,344 $9.53 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $883,312 - $971,422
-12,323 Reduced 6.88%
166,866 $12.5 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $43,592 - $48,217
620 Added 0.35%
179,189 $13.9 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $100,742 - $118,663
1,463 Added 0.83%
178,569 $13.8 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $86,411 - $95,898
-1,204 Reduced 0.68%
177,106 $14.5 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $5.27 Million - $5.97 Million
71,988 Added 67.71%
178,310 $14.8 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $1.31 Million - $1.49 Million
-18,652 Reduced 14.92%
106,322 $8.22 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $508,970 - $705,458
-8,033 Reduced 6.04%
124,974 $9.62 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $4.23 Million - $4.77 Million
-54,507 Reduced 29.07%
133,007 $12.1 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $326,687 - $356,101
4,294 Added 2.34%
187,514 $15.8 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $202,885 - $237,018
-2,905 Reduced 1.56%
183,220 $15.4 Million
Q1 2019

Jun 12, 2019

SELL
$69.58 - $79.36 $116,129 - $132,451
-1,669 Reduced 0.89%
186,125 $15.5 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $61,021 - $69,598
-877 Reduced 0.46%
187,794 $15.6 Million
Q4 2018

Feb 06, 2019

SELL
$65.24 - $75.71 $5.42 Million - $6.29 Million
-83,053 Reduced 30.57%
188,671 $14.4 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $574,880 - $676,025
-9,965 Reduced 3.54%
271,724 $19.3 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $8.68 Million - $10.2 Million
170,718 Added 153.84%
281,689 $17.1 Million
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $1.47 Million - $1.71 Million
28,887 Added 35.19%
110,971 $6.05 Million
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $886,986 - $1.06 Million
-17,183 Reduced 17.31%
82,084 $4.62 Million
Q3 2017

Nov 07, 2017

BUY
$58.67 - $63.13 $5.82 Million - $6.27 Million
99,267
99,267 $6.36 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.